L. Jin et al., PROLACTIN RECEPTOR MESSENGER-RIBONUCLEIC-ACID IN NORMAL AND NEOPLASTIC HUMAN PITUITARY TISSUES, The Journal of clinical endocrinology and metabolism, 82(3), 1997, pp. 963-968
We examined the specific cell types in normal human pituitaries that e
xpressed PRL receptor (PRL-R) messenger ribonucleic acid (mRNA) by com
bined in situ hybridization and immunohistochemistry. The distribution
of PRL-R mRNA in 28 pituitary adenomas was examined by in situ hybrid
ization and reverse transcription-PCR in 12 cases of adenomas. In anot
her set of experiments, 34 PRL adenomas fi om men, women, and bromocri
ptine-treated patients were analyzed for PRL-R by in situ hybridizatio
n. In the normal pituitary, PRL- and LH-producing cells had significan
tly more mean grain counts per cell and higher percentages of cells po
sitive for PRL-R than GH and TSH cells. PRL-R mRNA was present in all
groups of adenomas by in situ hybridization and reverse transcription-
PCR. PRL adenomas had a significantly higher density of labeling compa
red to other adenoma types. Although there was no difference in the le
vels of PRL-R mRNA in PRL adenomas from men and premenopausal and post
menopausal women, patients treated with bromocriptine before pituitary
surgery had significantly lower levels of PRL-R compared to all other
groups. These results indicate that in the normal pituitary, PRL and
LH cells have the highest level of PRL-R mRNA, whereas PRL adenomas ha
ve significantly higher levels of PRL-R mRNA than other types of adeno
mas, and bromocriptine treatment decreases the levels of PRL-R mRNA in
PRL adenomas.